
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc. is projecting substantial growth in client count for Q4 2025, contributing to an expected adjusted operating income margin of approximately 22.4%, which represents an increase of about 270 basis points year-over-year. The company has demonstrated a strong revenue growth of 53.3% alongside a significant expansion of its adjusted operating margin, highlighting improvements in operational efficiency and member outcomes. Additionally, the implementation of the Hinge Connect tool and new programming initiatives are anticipated to drive yields and further enhance the company’s growth trajectory, with penetration rates still below industry norms indicating potential for increased market share.
Bears say
Hinge Health is experiencing a concerning decline in its adjusted R&D expenses as a percentage of revenue, falling from 23.7% in 3Q24 to an anticipated 14.5% in 3Q25, potentially indicating reduced investment in innovation and development. The company's projected EBIT margins are also troubling, with a decline from a 19% EBIT margin in 2Q25 to mid-teens margins in the latter half of 2025, suggesting unsustainable profitability levels as anticipated margins for FY26 and FY27 remain relatively low. Additionally, the management's expectation of a sequential decline in membership and reliance on reduced marketing expenditures during the holiday season raises skepticism regarding the effectiveness of their strategies to enhance revenue growth.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares